| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672140 | Null | 0.00162803849483079 | 0.32982202 |
| NSC 672210 | Null | 0.00162803849483079 | 0.50019505 |
| NSC 672304 | Null | 0.00162803849483079 | 0.44730704 |
| NSC 684409 | 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone | 0.00162803849483079 | 0.33487841 |
| NSC 686551 | Null | 0.00162803849483079 | 0.48676267 |
| NSC 688228 | Null | 0.00162803849483079 | 0.1079368 |
| NSC 703784 | L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride | 0.00162803849483079 | 0.14959084 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.00162803849483079 | 0.26910762 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.00162803849483079 | 0.35772836 |
| NSC 744688 | Null | 0.00162803849483079 | 0.40099907 |